In Silico Methods for Development of Generic Drug–Device Combination Orally Inhaled Drug Products
The development of generic, single‐entity, drug–device combination products for orally inhaled drug products is challenging in part because of the complex nature of device design characteristics and the difficulties associated with establishing bioequivalence for a locally acting drug product delive...
| 出版年: | CPT: Pharmacometrics & Systems Pharmacology |
|---|---|
| 主要な著者: | , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2019-06-01
|
| オンライン･アクセス: | https://doi.org/10.1002/psp4.12413 |